Back to the main directory
EarningsReview / Equity
- Bilendi - Croissance au ralenti by MidCap Partners
- Q3 24 First Take: a mixed bag by BNP Paribas Exane
- ARCELORMITTAL: RDOS. 3T’24 (ANÁLISIS BANCO SABADELL) by Sabadell
- US launch of PRECISION7 weekly contact lenses by BNP Paribas Exane
- MedinCell - Good news on the Teva front by MidCap Partners
- Bilendi - Slow growth by MidCap Partners
- ICAPE HOLDING - No clear signs of a rebound in activity in sight by MidCap Partners
- INVEST SECURITIES - KLEPIERRE : De très bonnes performances, mais un titre correctement valorisé - NEUTRE vs ACHAT, OC 27,4€ vs 28,6€ by Invest Securities
- INVEST SECURITIES - TRANSGENE : TG4050 sur le point de délivrer ses messages à 24 mois - ACHAT, OC 2,6€ by Invest Securities
- INVEST SECURITIES - AIRWELL : Résister en 2024 avant le rebond attendu en 2025 - ACHAT, OC 4,5€ vs 4,7€ by Invest Securities
- 石头科技（688169 CH） by HSBC
- Solid State - H1 trading in line; guidance unchanged by Edison Investment Research
- ROVI: RDOS. 3T’24 (ANÁLISIS BANCO SABADELL) by Sabadell
- MT, APAM, STEEL CHINA by BNP Paribas Exane
- FQ1 25 results in line with lowered guidance by BNP Paribas Exane
- Nissan (NR) 2Q miss, announces major restructuring by BNP Paribas Exane
- Q3 conf call: The issue remains growth, not margins by BNP Paribas Exane
- Conf call feedback Can sales growth accelerate to 6% in Q4? by BNP Paribas Exane
- ARCELORMITTAL: 3Q’24 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- TELEFÓNICA: 3Q’24 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- Veolia conf call key points and views by BNP Paribas Exane
- Groupe SEB - First read on the Trump effect by MidCap Partners
- GS Retail (007070 KS) by HSBC
- Itaú BBA on Copel: Soft Recurring Results, as Expected by Itau
- Q2 FY25 conference call feedback by BNP Paribas Exane